TrademarkDir
FIDVAXI
LIVE

Serial Number

79352877

Owner

Genexine, Inc.

Attorney

LEIGH ANN LINDQUIST

Filing Date

Sep 1, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

FIDVAXI Trademark

Serial Number: 79352877 • Registration: 7227043

FIDVAXI is a trademark filed by Genexine, Inc. on September 1, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Genexine, Inc. (16 trademarks)

(Magokdong, Bio Innovation Park) 172,

Entity Type: 98

Trademark Details

Filing Date

September 1, 2022

Registration Date

November 28, 2023

Published for Opposition

September 12, 2023

Goods & Services

Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely, immunomodulators; viral vaccines; pharmaceutical preparations for the treatment of viral diseases; vaccines; vaccine preparations; pharmaceutical preparations and substances for use in gynecology; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases of cancer patients; biopharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; human vaccine preparations; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for suppressing tumors

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Feb 7, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 26, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 4, 2024 FICS
FINAL DISPOSITION PROCESSED
Mar 4, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 28, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 28, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 28, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Sep 12, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 12, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 12, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 23, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 23, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 23, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 4, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 6, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 6, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 6, 2023 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 13, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 13, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 13, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 13, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 13, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 13, 2023 COAR
REFUSAL PROCESSED BY IB
Feb 2, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 12, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jan 12, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 3, 2022 RFCR
NON-FINAL ACTION WRITTEN
Nov 2, 2022 CNRT
ASSIGNED TO EXAMINER
Nov 2, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 25, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 21, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 20, 2022 REPR

Related Trademarks

More from this Owner

HYFC TECHNOLOGY logo

HYFC TECHNOLOGY

HYFC TECHNOLOGY logo

HYFC TECHNOLOGY

HYFC TECHNOLOGY logo

HYFC TECHNOLOGY

EFESA logo

EFESA

EFESA logo

EFESA

EFESA logo

EFESA